Mikio Konishi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibodies and polypeptides. With a total of 6 patents, his work has had a substantial impact on medical research and treatment options.

Latest Patents

Konishi's latest patents include innovative developments related to antibodies targeting tumor necrosis factor (TNF) receptor family members. His patents detail the polypeptide produced from human stromal cell lines, the processes for preparing these polypeptides, and the DNA encoding them. Additionally, he has developed vectors carrying the DNA, host cells transformed by these vectors, and pharmaceutical compositions containing the polypeptides or antibodies.

Career Highlights

Throughout his career, Mikio Konishi has worked with notable companies such as Ono Pharmaceutical Co., Ltd. and Ono Pharmaceuticals Co., Ltd. His expertise in biopharmaceuticals has positioned him as a key figure in the industry, contributing to advancements in therapeutic solutions.

Collaborations

Konishi has collaborated with esteemed colleagues, including Mitoshi Konno and Tadamitsu Kishimoto. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Mikio Konishi's contributions to the field of biopharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com